BioPlus Acquisition Corp Performance
| BIOSDelisted Stock | USD 10.73 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0159, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BioPlus Acquisition's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioPlus Acquisition is expected to be smaller as well. BioPlus Acquisition Corp right now shows a risk of 0.0%. Please confirm BioPlus Acquisition Corp maximum drawdown, as well as the relationship between the expected short fall and day median price , to decide if BioPlus Acquisition Corp will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days BioPlus Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, BioPlus Acquisition is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 635.5 K |
BioPlus |
BioPlus Acquisition Relative Risk vs. Return Landscape
If you would invest 1,073 in BioPlus Acquisition Corp on September 1, 2024 and sell it today you would earn a total of 0.00 from holding BioPlus Acquisition Corp or generate 0.0% return on investment over 90 days. BioPlus Acquisition Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than BioPlus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
BioPlus Acquisition Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioPlus Acquisition's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BioPlus Acquisition Corp, and traders can use it to determine the average amount a BioPlus Acquisition's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BIOS |
Based on monthly moving average BioPlus Acquisition is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioPlus Acquisition by adding BioPlus Acquisition to a well-diversified portfolio.
BioPlus Acquisition Fundamentals Growth
BioPlus Stock prices reflect investors' perceptions of the future prospects and financial health of BioPlus Acquisition, and BioPlus Acquisition fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioPlus Stock performance.
| Return On Asset | -0.0072 | |||
| Current Valuation | 215.16 M | |||
| Shares Outstanding | 19.37 M | |||
| Price To Earning | (3.62) X | |||
| EBITDA | (1.17 M) | |||
| Cash And Equivalents | 294.69 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 5 M | |||
| Debt To Equity | 7.23 % | |||
| Book Value Per Share | (0.86) X | |||
| Cash Flow From Operations | (691.47 K) | |||
| Earnings Per Share | 0.21 X | |||
| Total Asset | 238.32 M | |||
| Retained Earnings | (14.78 M) | |||
| Current Asset | 183.69 M | |||
| Current Liabilities | 152.76 M | |||
About BioPlus Acquisition Performance
Assessing BioPlus Acquisition's fundamental ratios provides investors with valuable insights into BioPlus Acquisition's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the BioPlus Acquisition is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
BioPlus Acquisition Corp. does not have significant operations. The company was incorporated in 2021 and is based in New York, New York. Bioplus Acquisition operates under Shell Companies classification in the United States and is traded on NASDAQ Exchange.Things to note about BioPlus Acquisition Corp performance evaluation
Checking the ongoing alerts about BioPlus Acquisition for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioPlus Acquisition Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioPlus Acquisition is not yet fully synchronised with the market data | |
| BioPlus Acquisition has a very high chance of going through financial distress in the upcoming years | |
| BioPlus Acquisition Corp currently holds about 294.69 K in cash with (691.47 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 49.0% of the company shares are held by company insiders |
- Analyzing BioPlus Acquisition's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioPlus Acquisition's stock is overvalued or undervalued compared to its peers.
- Examining BioPlus Acquisition's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioPlus Acquisition's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioPlus Acquisition's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioPlus Acquisition's stock. These opinions can provide insight into BioPlus Acquisition's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |